Collegium Pharmaceutical Affirms FY2026 Sales Guidance of $825.000M-$855.000M vs $835.780M Est
Benzinga Newsdesk 5 hours ago
NewsGuidance
Collegium Pharmaceutical (NASDAQ:COLL) affirms FY2026 sales outlook from $825.000 million-$855.000 million to $825.000 million-$855.000 million vs $835.780 million estimate.
Collegium Pharmaceutical (NASDAQ:COLL) affirms FY2026 sales outlook from $825.000 million-$855.000 million to $825.000 million-$855.000 million vs $835.780 million estimate.